UK markets closed

Mirum Pharmaceuticals, Inc. (MIRM)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
24.46-0.03 (-0.12%)
At close: 04:00PM EDT
24.46 0.00 (0.00%)
After hours: 04:20PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts88910
Avg. Estimate-0.48-0.44-1.350.51
Low estimate-0.73-0.76-2.48-1.52
High estimate-0.23-0.07-0.252.47
Year ago EPS-0.8-1.94-3.94-1.35
Revenue estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts8898
Avg. Estimate70.17M75.41M317.24M420.68M
Low estimate63.7M71.8M310M378M
High estimate72.9M79.5M325.5M483.19M
Year ago sales28.69M30.44M186.37M317.24M
Sales growth (year/est)144.60%147.70%70.20%32.60%
Earnings history30/03/202329/06/202329/09/202330/12/2023
Est. EPS-0.94-0.79-0.63-0.24
Actual EPS-0.8-1.94-0.57-0.66
Difference0.14-1.150.06-0.42
Surprise %14.90%-145.60%9.50%-175.00%
EPS trendCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Current estimate-0.48-0.44-1.350.51
7 days ago-0.48-0.44-1.350.51
30 days ago-0.44-0.4-1.230.75
60 days ago-0.15-0.09-0.221.15
90 days ago-0.11-0.06-0.11.3
EPS revisionsCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/A1N/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesMIRMIndustrySector(s)S&P 500
Current qtr.40.00%N/AN/AN/A
Next qtr.77.30%N/AN/AN/A
Current year65.70%N/AN/AN/A
Next year137.80%N/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A